Lynne I. Wagner

University of North Carolina at Chapel Hill

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 86 papers. Top paper: “Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment”.

Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment

NEJM Evidence(2022)10.1056/evidoa2200097

N/A

5.0DataRank · unranked

139 citations

Ralph B. D’Agostino, Teresa Crotts, Karen Craver, Mary Helen Hackney, Jennifer H. Jordan +16 more

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Journal of Clinical Oncology(2020)10.1200/jco.19.01866

N/A

3.5DataRank · unranked

102 citations

Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina R. Yanez +14 more

Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

Journal of Clinical Oncology(2023)10.1200/jco.23.00377

N/A

2.3DataRank · unranked

46 citations

Fengmin Zhao, Ju‐Whei Lee, Edward H. Ip, John Devin Peipert, Noah Graham +11 more

Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2023.50844

N/A

0.978DataRank · unranked

33 citations

Fenghai Duan, Na An, Ilanan F. Gareen, JoRean D. Sicks, Gelareh Sadigh +12 more

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

Journal of Clinical Oncology(2024)10.1200/jco.23.01544

N/A

0.930DataRank · unranked

19 citations

Se Eun Kim, Wayne Harris, Sumanta K. Pal, Michael R. Pins, Jill Kolesar +13 more

Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis

Journal of Clinical Epidemiology(2020)10.1016/j.jclinepi.2020.02.002

N/A

0.798DataRank · unranked

204 citations

Andrea Benedetti, Ying Sun, Zelalem Negeri, Chen He, Yin Wu +76 more

Financial Hardship Among Patients With Early-Stage Colorectal Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.31967

N/A

0.696DataRank · unranked

13 citations

Fenghai Duan, Na An, Ilana D. Gareen, JoRean D. Sicks, Jennifer M. Suga +13 more

The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients

Journal of Geriatric Oncology(2023)10.1016/j.jgo.2023.101474

N/A

0.693DataRank · unranked

18 citations

Paul J. Catalano, Leon Lenchik, Robert D. Boutin, Xin Yao, Helga S. Marques +8 more

Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.29630

N/A

0.663DataRank · unranked

22 citations

Parash Mani Bhandari, Tiffany Dal Santo, Suiqiong Fan, Ying Sun, Chen He +125 more

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)

Cancer(2021)10.1002/cncr.34063

N/A

0.616DataRank · unranked

15 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415)

JACC CardioOncology(2023)10.1016/j.jaccao.2022.12.011

N/A

0.587DataRank · unranked

16 citations

Justin M. Canada, Jennifer H. Jordan, Amy C. Ladd, Kerryn W. Reding, Tonya Moore +19 more

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

European Urology Focus(2023)10.1016/j.euf.2023.06.006

N/A

0.587DataRank · unranked

49 citations

Xiangying Chu, Noah M. Hahn, Eugene J. Pietzak, Angela B. Smith, Daniel H. Shevrin +9 more

The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae209

N/A

0.584DataRank · unranked

15 citations

Kathleen Van Dyk, Sheri J. Hartman, Thuy T. Koll, Christina K. Cramer, Glenn J. Lesser +30 more

Validation of the Lee‐Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approach

Psycho-Oncology(2022)10.1002/pon.6076

N/A

0.544DataRank · unranked

12 citations

Junhao Pan, Edward H. Ip, Daniel L. Hall, Janet A. Tooze, Beverly J. Levine +5 more

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Cancer Medicine(2020)10.1002/cam4.3416

N/A

0.523DataRank · unranked

9 citations

Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg +10 more

ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.24.00526

N/A

0.442DataRank · unranked

11 citations

Fengmin Zhao, Tarah J. Ballinger, Sofia F. Garcia, Fei Shen, Shamsuddin Virani +19 more

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2137

N/A

0.330DataRank · unranked

8 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial trial

Contemporary Clinical Trials(2024)10.1016/j.cct.2024.107783

N/A

0.292DataRank · unranked

6 citations

Karly M. Murphy, Elizabeth L. Addington, Janet A. Tooze, Laurie E. McLouth, Dershung Yang +10 more

Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression – Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis

Journal of Affective Disorders(2024)10.1016/j.jad.2024.06.033

N/A

0.292DataRank · unranked

6 citations

Yin Wu, Brooke Levis, Suiqiong Fan, Ying Sun, Mingyao Xu +255 more

External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4

Methods(2022)10.1016/j.ymeth.2021.11.005

N/A

0.269DataRank · unranked

5 citations

Brooke Levis, Ying Sun, Felix H. Fischer, Pim Cuijpers, Scott B. Patten +116 more

Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT)

Hypertension(2024)10.1161/hypertensionaha.123.21817

N/A

0.268DataRank · unranked

3 citations

Ralph B. D’Agostino, Nathaniel S. O’Connell, Glenn J. Lesser, Fadi N. Salloum, Anika L Hines +11 more

Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events

Cancer(2021)10.1002/cncr.33992

N/A

0.266DataRank · unranked

4 citations

Santiago Saldana, Kathy D. Miller, Ruth C. Carlos, Ilana F. Gareen, Joseph A. Sparano +9 more

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]

BMC Public Health(2022)10.1186/s12889-022-13631-w

N/A

0.229DataRank · unranked

3 citations

Autumn W. Rasmussen, Lynne I. Wagner, JoRean D. Sicks, Ilana F. Gareen, Ruth C. Carlos +17 more

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07417-4

N/A

0.215DataRank · unranked

3 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131

Cancer(2024)10.1002/cncr.35187

N/A

0.208DataRank · unranked

3 citations

Fengmin Zhao, Ingrid A. Mayer, Amyé Tevaarwerk, Sofia F. Garcia, Carlos L. Arteaga +20 more

Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7018

N/A

0.203DataRank · unranked

2 citations

Yael Flamand, Naomi B. Haas, Anne O’Neill, Robert S. DiPaola, Pearl Subramanian +6 more

Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6514

N/A

0.189DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Kircher, B. Herman, Joanna M. Streck +14 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0.165DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108145

N/A

0.104DataRank · unranked

1 citations

Fenghai Duan, Ilana F. Gareen, Judy Hancock, JoRean D. Sicks, Maryanne Thangarajah +8 more

The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer

Cardio-Oncology(2024)10.1186/s40959-024-00233-1

N/A

0.104DataRank · unranked

1 citations

Kerry Reding, Ralph B. D’Agostino, Emily M. Heiston, Moriah P. Bellissimo, Kristine C. Olson +15 more

Adaptation of a Personalized Electronic Care Planning Tool for Cancer Follow-up Care: Formative Study

JMIR Formative Research(2022)10.2196/41354

N/A

0DataRank · unranked

2 citations

Pamela W. Duncan, Elyse Thakur, Nicole Puccinelli‐Ortega, John M. Salsman, Gregory B. Russell +6 more

Association between an electronic health record (EHR)–embedded frailty index and survival among older adults receiving cancer chemotherapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12009

N/A

0DataRank · unranked

8 citations

Scott Isom, Katherine E. Callahan, Nicholas M. Pajewski, Ümit Topaloĝlu, Lynne I. Wagner +5 more

Longitudinal changes in financial burden in patients with colorectal cancer treated with curative intent: Primary results of EAQ162CD.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6597

N/A

0DataRank · unranked

1 citations

Fenghai Duan, Ellen Underwood, Ilana F. Gareen, JoRean D. Sicks, Gelareh Sadigh +11 more

The impact of anthracycline-based chemotherapy on fatigue: Results from WF-97415.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e24115

N/A

0DataRank · unranked

0 citations

Beverly J. Levine, Shannon L. Mihalko, Heidi D. Klepin, Peter H. Brubaker, Tonya Calhoun +9 more

A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186—Trials in progress.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4185

N/A

0DataRank · unranked

0 citations

Paul J. Catalano, Leon Lenchik, Robert D. Boutin, Xin Yao, Shaalan Beg +9 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094

N/A

0DataRank · unranked

0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

Randomized trial of atorvastatin during and following receipt of doxorubicin for breast cancer and lymphoma (WF-98213).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12072

N/A

0DataRank · unranked

0 citations

Ralph B. D’Agostino, Teresa Crotts, Mary Helen Hackney, Jennifer H. Jordan, Bonnie Ky +15 more

Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.015

N/A

0DataRank · unranked

25 citations

Lari Wenzel, Chelsea McKinney, Lynne I. Wagner, David Cella, Giulia Fulci +10 more

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0420

N/A

0DataRank · unranked

7 citations

Ju‐Whei Lee, Angela Wangari Walter, Rachel Rosen, Ilana F. Gareen, Sheetal Mehta Kircher +17 more

Frailty status determined by an electronic health record embedded frailty index and hospitalization risk among older adults following the initiation of cancer chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12010

N/A

0DataRank · unranked

7 citations

Scott Isom, Kathryn E. Callahan, Nicholas M. Pajewski, Ümit Topaloĝlu, Lynne I. Wagner +5 more

“Clinical trials are space travel”: Factors of psychological response to recurrence among oncologists enrolling patients in treatment optimization trials

Cancer Medicine(2023)10.1002/cam4.6710

N/A

0DataRank · unranked

1 citations

Courtney Andrews, Stacey A. Ingram, Lisa Zubkoff, Nadine Tung, Lynne I. Wagner +4 more

Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the wake forest nCI community oncology research program (NCORP) research base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12076

N/A

0DataRank · unranked

1 citations

Emily V. Dressler, W. Mark Brown, Glenn J. Lesser, William P. Fusselman, Vinay Gudena +5 more

Qualitative similarities and distinctions between participants’ experiences with a yoga intervention and an attention control

Supportive Care in Cancer(2023)10.1007/s00520-023-07639-0

N/A

0DataRank · unranked

0 citations

David G. Schlundt, Kemberlee Bonnet, Gurjeet S. Birdee, Nancy E. Avis, Lynne I. Wagner +7 more

Patient reported quality of life (QOL) and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PCa).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5014

N/A

0DataRank · unranked

0 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynne I. Wagner +4 more

Smoking cessation support and knowledge among newly diagnosed individuals at community cancer centers (ECOG-ACRIN trial EAQ171CD).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1522

N/A

0DataRank · unranked

0 citations

Jamie S. Ostroff, JoRean D. Sicks, Brett M. Goshe, Ilana F. Gareen, B. Herman +14 more

A pilot randomized controlled trial of a mind-body resiliency program for fear of cancer recurrence: Qualitative findings.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.503

N/A

0DataRank · unranked

0 citations

Erika Tsuchiyose, Gloria Y. Yeh, Elyse R. Park, Lynne I. Wagner, Jeffrey Peppercorn +11 more

Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement

Cancer(2024)10.1002/cncr.35326

N/A

0DataRank · unranked

25 citations

Lynne I. Wagner, Sophie Lebel, Allan Ben Smith, Cristiane Decat Bergerot, Elyse R. Park +1 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102838

N/A

0DataRank · unranked

18 citations

Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill A. Bell, Vishal Bhatnagar +27 more

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.3854

N/A

0DataRank · unranked

21 citations

Fengmin Zhao, Ju‐Whei Lee, Shu-en Shen, Edward H. Ip, Nathaniel S. O’Connell +12 more

Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials

Journal of Pain and Symptom Management(2024)10.1016/j.jpainsymman.2024.12.021

N/A

0DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Mehta Kircher, Shaji Kumar, Ingrid A. Mayer +10 more

Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD)

Nicotine & Tobacco Research(2024)10.1093/ntr/ntae304

N/A

0DataRank · unranked

2 citations

Jo Rean D Sicks, Lynne I. Wagner, Ruth C. Carlos, Isabelle Miranda, Rachel L Rosen +17 more

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Research Square(2024)10.21203/rs.3.rs-4295044/v1

N/A

0DataRank · unranked

0 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

UNC Libraries(2024)10.17615/ypmf-1g37

N/A

0DataRank · unranked

0 citations

Melanie Calvert, Steven Rizk, Philip Collis, Alastair Greystoke, Bellinda L. King‐Kallimanis +27 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Patient-reported pain severity is associated with shorter survival in older adults with newly diagnosed cancer

Supportive Care in Cancer(2025)10.1007/s00520-025-09779-x

N/A

0DataRank · unranked

2 citations

Scott Isom, Tiffany M. Statler, Joanna Asselin, Kathryn E. Callahan, Nicholas M. Pajewski +5 more

Effectiveness of out-of-pocket cost COMmunication and financial navigation (CostCOM) in cancer patients: Study protocol for ECOG-ACRIN EAQ222CD

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107889

N/A

0DataRank · unranked

0 citations

Fenghai Duan, Ilana F. Gareen, Judy Hancock, JoRean D. Sicks, Sarah T. Hawley +5 more

The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials

UNC Libraries(2025)10.17615/c1xc-d466

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Sheetal Mehta Kircher, Lynne I. Wagner, Frank S. Hodi, Jamie S. Ostroff +16 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148

N/A

0DataRank · unranked

115 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/6e7v-pv95

N/A

0DataRank · unranked

1 citations

Tracy Lively, John A. Olson, Robert J. Gray, Virginia Kaklamani, Della Makower +26 more

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Results of ENDURANCE (E1A11) phase III trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.18_suppl.lba3

N/A

0DataRank · unranked

31 citations

Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina A. Singh +15 more

Increase in side effect bother was associated with early treatment discontinuation in a clinical trial among multiple myeloma patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19136

N/A

0DataRank · unranked

5 citations

Fengmin Zhao, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +9 more

Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19132

N/A

0DataRank · unranked

3 citations

John Devin Peipert, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +15 more

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22078

N/A

0DataRank · unranked

1 citations

Yue Zheng, Sandra J. Lee, F. Stephen Hodi, UMA RAO, Gary I. Cohen +4 more

Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7004

N/A

0DataRank · unranked

1 citations

Robert J. Gray, Joseph A. Sparano, Ruth C. Carlos, Gelareh Sadigh, Sofia F. Garcia +6 more

Breast cancer patients’ insurance status correlates with their adherence to endocrine therapy: Analysis of ECOG-ACRIN TAILORx trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7041

N/A

0DataRank · unranked

0 citations

Robert J. Gray, Betina R. Yanez, Lynne I. Wagner, Sofia F. Garcia, Joseph A. Sparano +3 more

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community Oncology Research Program (NCORP; EAQ152) COMET trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2008

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021204743

N/A

0DataRank · unranked

38 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG‐ACRIN TAILORx trial

Cancer(2021)10.1002/cncr.33527

N/A

0DataRank · unranked

29 citations

Robert J. Gray, Joseph A. Sparano, Betina R. Yanez, Sofia F. Garcia, Lava Timsina +5 more

A Randomized Controlled Pilot Study of Yoga Skills Training Versus an Attention Control Delivered During Chemotherapy Administration

Journal of Pain and Symptom Management(2021)10.1016/j.jpainsymman.2021.07.022

N/A

0DataRank · unranked

22 citations

Janet A. Tooze, Emily Johnson, Sheila H. Ridner, Russell L. Rothman, Caio Rocha Lima +6 more

Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.29697

N/A

0DataRank · unranked

15 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +7 more

Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy

Cancer(2021)10.1002/cncr.33939

N/A

0DataRank · unranked

5 citations

Robert J. Gray, Joseph A. Sparano, Amyé Tevaarwerk, Ruth C. Carlos, Betina R. Yanez +6 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021219016

N/A

0DataRank · unranked

5 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

ECOG-ACRIN E1411 randomized phase 2 trial of bendamustine-rituximab (BR)-based induction followed by rituximab (R) ± lenalidomide (L) consolidation for Mantle cell lymphoma: Effect of adding bortezomib to front-line BR induction on PFS.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7503

N/A

0DataRank · unranked

19 citations

Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir Parekh, David T. Yang +15 more

A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.605

N/A

0DataRank · unranked

7 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +12 more

Social determinants of health, genetic ancestry, and mortality in ECOG-ACRIN E5103.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6527

N/A

0DataRank · unranked

3 citations

Anne O’Neill, Kathy D. Miller, Bryan P. Schneider, Ann H. Partridge, Lava Timsina +4 more

Biomarker testing in non-small cell lung cancer (NSCLC): An assessment of current practices in precision oncology in the community setting—A trial of the ECOG-ACRIN cancer research group (EAQ161CD).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18649

N/A

0DataRank · unranked

2 citations

JoRean D. Sicks, Christine B. Weldon, Gregory J. Tsongalis, Bruce D. Rapkin, Kathryn E. Weaver +11 more

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12003

N/A

0DataRank · unranked

2 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Reply to T. Shimoi et al and Y. Shimanuki et al

Journal of Clinical Oncology(2021)10.1200/jco.21.01905

N/A

0DataRank · unranked

2 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +20 more

Association between allostatic load, symptom burden and mortality in E1A11 trial for myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12102

N/A

0DataRank · unranked

0 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, David Cella, Fengmin Zhao +9 more

Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: Early results of ECOG-ACRIN EAQ162CD.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1518

N/A

0DataRank · unranked

0 citations

Fenghai Duan, Ilana F. Gareen, Ellen Underwood, JoRean D. Sicks, Jennifer M. Suga +7 more

Predictors of surgery preference and quality of life in DCIS after breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (E4112).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6564

N/A

0DataRank · unranked

0 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +14 more

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac166

N/A

0DataRank · unranked

39 citations

Susan K. Parsons, Patricia A. Ganz, Lynne I. Wagner, Pamela S. Hinds, Sarah Alexander +14 more

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients

Blood Cancer Journal(2022)10.1038/s41408-022-00648-y

N/A

0DataRank · unranked

25 citations

Noah Graham, Shaji Kumar, Ju‐Whei Lee, Susanna Jacobus, Matthias Weiss +12 more

“I need more knowledge”: Qualitative analysis of oncology providers’ experiences with sexual and gender minority patients

Frontiers in Psychology(2022)10.3389/fpsyg.2022.763348

N/A

0DataRank · unranked

14 citations

Edith P. Mitchell, Lynne I. Wagner, Melissa A. Simon, Ruth C. Carlos, Bruce J. Giantonio +3 more

A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention

Journal of Behavioral Medicine(2022)10.1007/s10865-022-00349-8

N/A

0DataRank · unranked

12 citations

Beverly J. Levine, Elizabeth Jeter, Allison Chandler, Janet A. Tooze, Jenna Duffecy +10 more